Sort
17,054 grants matching “genome editing”
A Cancer Rainbow Mouse for Simultaneous Assessment of Multiple Oncogenes
$393,463Marc G. Caron · Duke University · R33 · FY2017 · CA
Genetic Variants Associated with Alzheimer's disease and Related Dementias
$393,375Mark Cookson · National Institute On Aging · ZIA · FY2023 · AG
Gene Targeting Facility
$393,304Lino Tessarollo · Division Of Basic Sciences - Nci · ZIC · FY2018 · CA
Viral RNA Modifying Enzymes
$393,218Sloan-Kettering Institute For Cancer Res · R01 · FY2002 · GM
Molecular and cellular basis of epidermodysplasia verruciformis
$393,127Jean-Laurent Casanova · Rockefeller University · R01 · FY2022 · AI
REU SITE: Summer Undergraduate Program for Experiential Research (SUPER) in Molecular Biosciences.
$393,089Antonio Gonzalez · University Of Texas At Austin · · FY2020 · BIO
TET-mediated epigenetic regulation in cardiac development.
$393,056Yun Huang · Texas A&M University Health Science Ctr · R01 · FY2018 · HL
Mitochondrial dynamics protein Drp1 regulation of endothelial metabolism, ROS, and ischemic vascular disease
$392,997Masuko Ushio-Fukai · Augusta University · P01 · FY2025 · HL
Mitochondrial dynamics protein Drp1 regulation of endothelial metabolism, ROS, and ischemic vascular disease
$392,997Masuko Ushio-Fukai · Augusta University · P01 · FY2024 · HL
Collaborative Research: IMAGiNE: Quantifying Diatom Resilience in an Acidified Ocean
$392,981Virginia Armbrust · University Of Washington · · FY2021 · BIO
Biodegradable nanoparticles, a genome editing platform to treat hemophilia
$392,900Yizhou Dong · Ohio State University · R01 · FY2021 · HL
Exploring Blood-Brain Barrier Dysfunction in Alzheimer's Disease
$392,861Eric V Shusta · University Of Wisconsin-Madison · R01 · FY2018 · NS
Molecular and functional characterization of olfactory pathways in the arbovirus vector mosquito Aedes aegypti
$392,850Carolyn Sarah McBride · Princeton University · R01 · FY2025 · AI
Engineering smart cells for arthritis therapy
$392,761Farshid Guilak · Washington University · R61 · FY2019 · AR
Biology and Biotechnology of Cell and Gene Therapy
$392,760David V Schaffer · University Of California Berkeley · T32 · FY2025 · GM
Biodegradable nanoparticles, a genome editing platform to treat hemophilia
$392,751Yizhou Dong · Ohio State University · R01 · FY2020 · HL
Mechanisms of resistance to ALK inhibitors in ALK-rearranged lymphoma
$392,740Roberto Chiarle · Boston Children'S Hospital · R01 · FY2019 · CA
APOBEC proteins as drivers of chromosomal translocations in solid cancers
$392,740Roberto Chiarle · Boston Children'S Hospital · R01 · FY2019 · CA
Unraveling the pathogenesis of familial dilated cardiomyopathy towards precision medicine
$392,710Ioannis Karakikes · Stanford University · R01 · FY2018 · HL
Mouse Models Will Elucidate Genetics of CDH and Associated Pulmonary Defects and Identify Clinically Relevant Targets
$392,697Patricia K Donahoe · Massachusetts General Hospital · P01 · FY2017 · HD
Unraveling the pathogenesis of familial dilated cardiomyopathy towards precision medicine
$392,696Ioannis Karakikes · Stanford University · R01 · FY2019 · HL
Unraveling the pathogenesis of familial dilated cardiomyopathy towards precision medicine
$392,682Ioannis Karakikes · Stanford University · R01 · FY2020 · HL
Unraveling the pathogenesis of familial dilated cardiomyopathy towards precision medicine
$392,667Ioannis Karakikes · Stanford University · R01 · FY2021 · HL
Biodegradable nanoparticles, a genome editing platform to treat hemophilia
$392,607Yizhou Dong · Ohio State University · R01 · FY2019 · HL
Multimodality Molecular Imaging of Stem Cell Therapy for Ischemic Cardiomyopathy
$392,587Patricia Kim Phuong Nguyen · Stanford University · R01 · FY2019 · HL